Single-pill combination in the management of chronic coronary syndromes: A strategy to improve treatment adherence and patient outcomes?
Articolo
Data di Pubblicazione:
2023
Citazione:
Single-pill combination in the management of chronic coronary syndromes: A strategy to improve treatment adherence and patient outcomes? / F.J. Pinto, M.F. Piepoli, R. Ferrari, K. Tsioufis, G.M.C. Rosano, A. Nedoshivin, J.C. Kaski. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 1874-1754. - 384:(2023 Aug 01), pp. 10-17. [10.1016/j.ijcard.2023.04.046]
Abstract:
Chronic coronary syndrome (CCS) represents a major challenge for physicians, particularly in the context of an increasing aging population. Additionally, CCS is often underestimated and under-recognised, particularly in female patients. As patients are frequently affected by several chronic comorbidities requiring polypharmacy, this can have a negative impact on patients' adherence to treatment. To overcome this barrier, single-pill combination (SPC), or fixed-dose combination, therapies are already widely used in the management of conditions such as hypertension, dyslipidaemia, and diabetes mellitus. The use of SPC anti-anginal therapy deserves careful consideration, as it has the potential to substantially improve treatment adherence and clinical outcomes, along with reducing the failure of pharmacological treatment before considering other interventions in patients with CCS.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Adherence; Angina; Chronic coronary syndrome; Comorbidities; Single-pill combination; Treatment
Elenco autori:
F.J. Pinto, M.F. Piepoli, R. Ferrari, K. Tsioufis, G.M.C. Rosano, A. Nedoshivin, J.C. Kaski
Link alla scheda completa:
Link al Full Text: